The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Q4FY26 revenue climbs 19% to Rs. 2,290 crore as CDMO sterile injectables, radiopharma and generics businesses drive growth momentum
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The 50,000 square foot expansion will house a high-speed filling line and lyophilizers, which will increase the facility’s sterile injectable capacity by 50%
This investment is being made to set up a high speed 400 vials a minute injectable fill line with isolator technology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
